PlexusDx offers the Precision Peptide Genetic Testa peptide-pathway genetic analysis (not pharmacogenomic testing) that examines 14 biological pathways and 150+ genetic insights relevant to GLP-1 therapy response
Weight Loss Results: What the Data Shows When it comes to shedding pounds, injectable GLP-1s deliver superior results based on extensive clinical trials: Injectable semaglutide (Wegovy ) : 15-17% average body weight loss Injectable tirzepatide (Mounjaro /Zepboun d) : Up to 22.5% average body weight loss FDA-approved oral semaglutide: 13.6-16.6% average body weight loss Compounded ODT formulations : No published clinical trial data available A real-world comparison study found that patients on injectable semaglutide lost 1.62kg more than those on FDA-approved oral semaglutide over 26 weeks, which was not significant
FIRST VISIT & 8-WEEK INITIAL PROGRAM During the first appointment & dose, you will be weighed, have your body measurements taken, review best lifestyle practices and expectations while taking these treatments, and your provider will administer your first dose
It enhances glucose-dependent insulin secretion (meaning it prompts insulin release primarily when blood sugar is elevated), slows gastric emptying so a meal leaves the stomach more gradually, and acts on appetite centers in the brain to promote a feeling of fullness
You do not need to stop using peptides before testing